Charles Schwab’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,709
| Closed | -$27K | – | 3587 |
|
|
2023
Q2 | $27K | Hold |
1,709
| – | – | ﹤0.01% | 3523 |
|
|
2023
Q1 | $38.6K | Hold |
1,709
| – | – | ﹤0.01% | 3387 |
|
|
2022
Q4 | $61K | Hold |
1,709
| – | – | ﹤0.01% | 3321 |
|
|
2022
Q3 | $67K | Sell |
1,709
-5,499
| -76% | -$216K | ﹤0.01% | 3264 |
|
|
2022
Q2 | $346K | Sell |
7,208
-4,874
| -40% | -$234K | ﹤0.01% | 3169 |
|
|
2022
Q1 | $1.12M | Buy |
12,082
+428
| +4% | +$39.6K | ﹤0.01% | 2809 |
|
|
2021
Q4 | $2.59M | Buy |
11,654
+539
| +5% | +$120K | ﹤0.01% | 2616 |
|
|
2021
Q3 | $3.85M | Buy |
11,115
+523
| +5% | +$181K | ﹤0.01% | 2490 |
|
|
2021
Q2 | $3.98M | Buy |
10,592
+629
| +6% | +$236K | ﹤0.01% | 2456 |
|
|
2021
Q1 | $3.09M | Buy |
9,963
+219
| +2% | +$68K | ﹤0.01% | 2526 |
|
|
2020
Q4 | $2.44M | Buy |
9,744
+216
| +2% | +$54K | ﹤0.01% | 2538 |
|
|
2020
Q3 | $1.76M | Buy |
9,528
+5,232
| +122% | +$967K | ﹤0.01% | 2535 |
|
|
2020
Q2 | $1.07M | Buy |
4,296
+677
| +19% | +$169K | ﹤0.01% | 2602 |
|
|
2020
Q1 | $655K | Buy |
3,619
+11
| +0.3% | +$1.99K | ﹤0.01% | 2615 |
|
|
2019
Q4 | $1.5M | Buy |
3,608
+1,924
| +114% | +$802K | ﹤0.01% | 2485 |
|
|
2019
Q3 | $424K | Buy |
1,684
+83
| +5% | +$20.9K | ﹤0.01% | 2866 |
|
|
2019
Q2 | $637K | Buy |
+1,601
| New | +$637K | ﹤0.01% | 2716 |
|